IDEXX Laboratories, Inc. (LON:0J8P)
London · Delayed Price · Currency is GBP · Price in USD 724.30
+90.16 (14.22%)
At close: Nov 3, 2025
IDEXX Laboratories Market Cap
IDEXX Laboratories has a market cap or net worth of 44 billion as of November 3, 2025. Its market cap has increased by 51.18% in one year.
Market Cap
44.00B
Enterprise Value
44.59B
Revenue
3.10B
Ranking
n/a
PE Ratio
57.56
Stock Price
724.30
Market Cap Chart
Since June 21, 1991, IDEXX Laboratories's market cap has increased from 42.95M to 44.00B, an increase of 102,329.98%. That is a compound annual growth rate of 22.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 44.00B | 62.70% |
| Dec 31, 2024 | 27.04B | -25.28% |
| Dec 29, 2023 | 36.19B | 29.06% |
| Dec 30, 2022 | 28.04B | -32.00% |
| Dec 31, 2021 | 41.23B | 32.03% |
| Dec 31, 2020 | 31.23B | 84.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |